1. Home
  2. TPST vs CENN Comparison

TPST vs CENN Comparison

Compare TPST & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • CENN
  • Stock Information
  • Founded
  • TPST 2011
  • CENN 2013
  • Country
  • TPST United States
  • CENN United States
  • Employees
  • TPST N/A
  • CENN N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • CENN Auto Manufacturing
  • Sector
  • TPST Health Care
  • CENN Consumer Discretionary
  • Exchange
  • TPST Nasdaq
  • CENN Nasdaq
  • Market Cap
  • TPST 33.0M
  • CENN 30.4M
  • IPO Year
  • TPST N/A
  • CENN N/A
  • Fundamental
  • Price
  • TPST $7.71
  • CENN $0.55
  • Analyst Decision
  • TPST Hold
  • CENN
  • Analyst Count
  • TPST 3
  • CENN 0
  • Target Price
  • TPST $30.00
  • CENN N/A
  • AVG Volume (30 Days)
  • TPST 94.5K
  • CENN 669.4K
  • Earning Date
  • TPST 08-07-2025
  • CENN 08-12-2025
  • Dividend Yield
  • TPST N/A
  • CENN N/A
  • EPS Growth
  • TPST N/A
  • CENN N/A
  • EPS
  • TPST N/A
  • CENN N/A
  • Revenue
  • TPST N/A
  • CENN $31,097,533.00
  • Revenue This Year
  • TPST N/A
  • CENN N/A
  • Revenue Next Year
  • TPST N/A
  • CENN N/A
  • P/E Ratio
  • TPST N/A
  • CENN N/A
  • Revenue Growth
  • TPST N/A
  • CENN 234.45
  • 52 Week Low
  • TPST $5.35
  • CENN $0.51
  • 52 Week High
  • TPST $28.34
  • CENN $1.70
  • Technical
  • Relative Strength Index (RSI)
  • TPST 59.30
  • CENN 35.04
  • Support Level
  • TPST $7.13
  • CENN $0.60
  • Resistance Level
  • TPST $8.75
  • CENN $0.65
  • Average True Range (ATR)
  • TPST 0.45
  • CENN 0.04
  • MACD
  • TPST 0.13
  • CENN 0.00
  • Stochastic Oscillator
  • TPST 63.83
  • CENN 27.27

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

Share on Social Networks: